InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,071.63
(
0.02%
)
US TECH 100
16,868.40
(
-0.79%
)
Dow Jones
38,460.92
(
-0.11%
)
Brent Oil
87.11
(
-0.13%
)
Bitcoin
64,303.14
(
0.03%
)
Post# of 135
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Horror_ Fn

Send PM Follow Ignore
Followers 0
Posts 107
Boards Moderated 0
Alias Born 02/16/2007

Horror_ Fn

Re: Horror_ Fn post# 111

Thursday, 03/01/2007 5:52:07 PM

Thursday, March 01, 2007 5:52:07 PM

Post# of 135
EGENE IS A BUY over a BUCK!

Their income is higher every quarter by over 100% and will continue to grow. They will soon be able to charge more for their product as the need grows and that will increase their profit margin. They are continuing to sign more contracts and customer chains!

Bottom line:

GROWTH

and for the biotech sector, this is a rare occurrence.

Target 2.09

get in now or soon and that'll be just fine!

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up